Cefazolin access and use in Ethiopia: A policy implication.

Autor: Alemkere G; Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Teshome A; Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Temesgen G; Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Abebe G; Department of Surgery, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Degefaw Y; Antimicrobial Resistance Prevention and Control Case Team, Pharmaceuticals and Medical Equipment Directorate, Ministry of Health, Addis Ababa, Ethiopia., Tilahun H; Department of Surgery, Gimjabet Primary Hospital, Gimjabet, Amhara, Ethiopia., Getahun W; Antimicrobial Resistance and Global Partnership, USAID Medicines, Technologies, and Pharmaceutical Services Program, Management Sciences for Health, Addis Ababa, Ethiopia., Girma E; Department of Preventive Medicine, School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Amogne W; Department of Infectious Diseases, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Publikováno v: PLOS global public health [PLOS Glob Public Health] 2023 Jan 17; Vol. 3 (1), pp. e0001421. Date of Electronic Publication: 2023 Jan 17 (Print Publication: 2023).